|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's Range||129.61 - 132.75|
|52 Week Range||109.82 - 174.79|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-11.48%|
|Beta (5Y Monthly)||1.23|
|Expense Ratio (net)||0.35%|
Building a core satellite ETF portfolio can give investors the best of two worlds.
ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.
Biotech ETFs shot higher Monday after the FDA formally approved Pfizer's vaccine. Trade the group's two largest funds with these tactical ideas.